Viewing Study NCT01045304


Ignite Creation Date: 2025-12-24 @ 9:08 PM
Ignite Modification Date: 2025-12-31 @ 4:56 AM
Study NCT ID: NCT01045304
Status: COMPLETED
Last Update Posted: 2014-01-14
First Post: 2010-01-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of SAR240550 (BSI-201) in Combination With Gemcitabine/Carboplatin, in Patients With Metastatic Triple Negative Breast Cancer
Sponsor: Sanofi
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module